Home/Filings/4/0001140361-11-011700
4//SEC Filing

Lalach Harvey 4

Accession 0001140361-11-011700

CIK 0001314052other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:02 PM ET

Size

9.4 KB

Accession

0001140361-11-011700

Insider Transaction Report

Form 4
Period: 2011-02-18
Lalach Harvey
DirectorPresident CEO CFO
Transactions
  • Sale

    common stock

    2011-02-18$3.75/sh3,000$11,250597,000 total
  • Sale

    common stock

    2011-02-18$3.74/sh1,628$6,089595,372 total
Holdings
  • common stock

    600,000
  • stock options

    Exercise: $3.10From: 2008-06-03Exp: 2013-06-03common stock (150,000 underlying)
    150,000
  • stock options

    Exercise: $3.50From: 2010-06-29Exp: 2015-06-29common stock (50,000 underlying)
    200,000

Documents

1 file

Issuer

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052

Entity typeother

Related Parties

1
  • filerCIK 0001360545

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:02 PM ET
Size
9.4 KB